| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020203558 |
Resistant |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.026209648 |
Sensitive |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045004324 |
Sensitive |
